LON:AZN

[ad_1] Shore Capital reiterated their buy rating on shares of AstraZeneca (LON:AZN) in a research report sent to investors on Thursday, June 27th, ThisIsMoney.Co.Uk reports. A number of other equities research analysts also recently issued reports on the company. Deutsche Bank reduced their price target on from GBX 217 ($2.84) to GBX 175 ($2.29) and…